Skip to content
Taxonomy
New Law Makes Flying Easier for People Living With Charcot-Marie-Tooth Disease
A partnership between the Charcot-Marie-Tooth Association (CMTA), Muscular Dystrophy Association Read More
CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth Read More
TAKE ACTION! Sign the Petition to Accelerate CMT-SORD
What is CMT-SORD? In 2019, with Charcot-Marie-Tooth Association (CMTA) funding, Read More
Leading the Way: The CMTA Invests More Than $200K in Cutting-Edge CMT1A Organoid Research
The CMTA’s new $200K+ investment accelerates CMT1A organoid research, revolutionizing Read More
The CMTA Mourns the Loss of Scientific Advisory Board Member and Esteemed CMT Clinical Researcher
It is with the heaviest of hearts that the Charcot-Marie-Tooth Read More
CMT2S Breakthrough
In a recent announcement, Vanda Pharmaceuticals Inc. shared that the Read More
CMTA Alliance Partner, Applied Therapeutics, Announces Positive 12-Month Results in its Ongoing INSPIRE Phase III Trial for CMT-SORD
In a statement released on February 15, 2024, by Charcot-Marie-Tooth Read More
The CMTA Appoints Professor Charlotte Sumner, M.D., to its Scientific Advisory Board
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth Read More
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
GLENOLDEN, Pa., November 6, 2023 – The Charcot-Marie-Tooth Association announced Read More
CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice
The Charcot-Marie-Tooth (CMT) Association announced a $33,000 grant on April Read More